Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?

Author： Cox M.  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.88, Iss.3, 2009-03, pp. : 283-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

By Oktenli Cagatay  

International Journal of Hematology, Vol. 95, Iss. 4, 2012-04 ,pp. : 380-385

Springer Publishing Company

Access to resources Recommend Favorite

Antiangiogenesis in hematologic diseases

By Beranek Jiri  

Annals of Hematology, Vol. 80, Iss. 4, 2001-04 ,pp. : 251-252

Springer Publishing Company

Access to resources Recommend Favorite

Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation

By Rosenau J.   Tillmann H.L.   Bahr M.J.   Trautwein C.   Boeker K.H.W.   Nashan B.   Klempnauer J.   Manns M.P.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3637-3638

Elsevier

Access to resources Recommend Favorite

Autoantibodies in patients with asthma: is there a link between asthma and autoimmunity?

By Konstantinidis Theocharis G.  

International Journal of Immunological Studies, Vol. 1, Iss. 4, 2012-12 ,pp. : 376-387

Inderscience Publishers

Access to resources Recommend Favorite

CMV in critically ill patients: pathogen or bystander?

By Limaye Ajit P.   Boeckh Michael  

Reviews in Medical Virology, Vol. 20, Iss. 6, 2010-11 ,pp. : 372-379

John Wiley & Sons Inc

Access to resources Recommend Favorite